Jeff Burris Email & Phone Number

Richmond, Va, Us

Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat addiction.As Chief Legal Officer, serve as the strategic legal executive and counselor to the CEO, the Executive Committee and Board of Directors. Additionally, our 16-member global legal team (11 attorneys) manages all legal issues of the company, including mergers & acquisitions, licensing, litigation, contracts, regulatory and business issues along with legal advice to support the compliance function.• Rebuilt almost the entire legal team and completed its organization structure by hiring or promoting ten individuals.• Negotiated, closed and helped with the integration of a publicly traded company, Opiant Pharmaceuticals, and assisted with obtaining the approval of their drug candidate with the FDA• Assisted with the secondary and primary listing of Indivior (INDV) on Nasdaq• Settled significant litigation• Acquired and helped with integration of a new manufacturing facility

General Counsel and Chief Compliance Officer of Arbor Pharmaceuticals. Arbor Pharmaceuticals, headquartered in Atlanta, Georgia, was a specialty pharmaceutical company with over 300 employees focused on the cardiovascular, neurology, endocrinology and orphan markets. • Was lead in-house attorney on private sale of Arbor Pharmaceuticals to Azurity Pharmaceuticals, and led all Arbor legal negotiations (size of transaction is private)• After close of transaction, one of only two Arbor representatives on steering committee for integration of Arbor and Azurity• Led all M&A legal deal negotiation drafting for all Arbor business development transactions, including in and out licensing transactions in cost effective manner• Drafted, negotiated, and reviewed all material contracts for the Company in cost effective manner including PBM, insurance and contract manufacturing agreements, along with vendor and supply agreements, licensing agreements and clinical trial agreements• Managed IP litigation, including Paragraph IV challenges and strategy • Managed a significant Lanham Act case to a favorable settlement• Supported regulatory efforts on complicated regulatory/legal issues, including filing a lawsuit against the FDA over its interpretation of regulation and statutes.• Implemented contract review and management system to allow for additional timely support for review in a cost-effective manner without additional headcount• As Chief Compliance Officer, managed all complaince matters, including review of promotional materials and provided guidance and support to business on issues associated with compliant promotion, including investigations and disciplinary actions • Senior Director of HR was a direct report• As Secretary, managed all corporate board activities from a corporate governance standpoint

General Counsel, Compliance Officer and Corporate Secretary of Alimera Sciences (NASDAQ: ALIM), a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals.Was member of the Company’s Executive Committee, and managed all Legal and Compliance issues of Alimera • Developed and implemented Compliance function of the Company, including: build out of Compliance programs, policies and procedures; training employees and consultants on compliance; and monitoring and auditing.• Lead legal deal negotiation and due diligence for Business Development & Licensing transactions• Managed SEC reporting, including all reporting act filing, along with Company press release and presentation review.• Managed all other legal and corporate governance issues, including contract review, employment and litigation matters.

Led and managed legal department of five employees and also HR Department. Managed all SEC reporting requirements and provided legal advice to Board. Directed all legal aspects of M&A, IP and litigation. • Led all legal deal negotiation, due diligence and integration for M&A transactions (including a publicly traded company) consisting of acquisitions, equity/debt investments, distribution and licensing arrangements• Managed all SEC reporting, along with management of Disclosure Review Committee, drafting and preparation of the Proxy and review of press releases and presentations• Managed, negotiated and reviewed all material contracts to the Company and oversaw all contract review • Reduced costs and increased efficiencies, accountability and transparency for review and management of all contracts through development and implementation of a sophisticated contract review process• Significantly reduced product liability cases and outside product liability spend over tenure• Managed significant litigation activities, including successfully obtaining a favorable commercial settlement of $4.7 million for the Company, while limiting company costs by obtaining favorable insurance reimbursement• Reduced costs, increased efficiencies and enhanced business strategy by consolidating all IP activities from a number of outside legal firms to one• Increased Company value and supported business development strategy by increasing invention disclosures and by instituting a cross-disciplinary patent disclosure review team• Developed and/or enhanced all compliance programs, including FCPA, Code of Business Conduct and PPSA. Developed and instituted training programs for all compliance programs• Managed a reorganization of the HR department to reposition it for the Company’s planned growth, including hiring of new recruiting and HR support personnel• Reviewed all Company advertising and promotional material to ensure compliance with FDA regulations and law.

Houston, Texas, Us

Led and managed all acquisitions and divestitures in Waste Management’s Southern Group (12 states and Puerto Rico; approx. $3 billion in revenue). Provided legal support and legal advice throughout the Southern Group• Closed over 70 acquisitions and divestitures during tenure, including landfill acquisitions and transfer station acquisitions with significant regulatory components representing a collective purchase price of over $120M• Reduced outside legal spend by drafting, reviewing and negotiating various sales, service and support contracts• Managed litigation issues and regulatory issues associated with various business areas• Negotiated successfully with governmental agencies on regulatory issues regarding compliance and operational issues to the benefit of the Company without costly litigation.• Assisted successfully with internal investigations of employees

Atlanta, Georgia, Us

Led and assisted with numerous M&A and licensing transactions as both lead and secondary counsel, with a focus on small to midsize companies. Member of the corporate as a commercial transactions attorney involved in negotiating, drafting and reviewing contracts for companies. In addition, developed and prepared forms and training for contracts for clients to allow them to reduce their costs. Contract expertise included distribution, franchising, supply, licensing and confidential disclosure agreements.

J.D., Law

B.A., Majored In Economics And History, Minor In Business